Prof Cheng-Hock Toh MBChB, MD, FRCP, FRCPath

Professor(Clin,Hcc) Clinical Infection, Microbiology and Immunology

    Biography

    Personal Statement

    I am a clinical academic with an interest in Haemostasis & Thrombosis. The clinical and research work is directed from the Roald Dahl Haemostasis & Thrombosis Centre in Liverpool. This is where we are primarily focussed on how coagulation abnormalities affect patient outcome and how its re-equilibration can lead to clinical improvement.

    Personal Distinctions

    • Invited Speaker (Invitation to Speak, German Congress of Anaesthesiology 2007)
    • Invited speaker (Invitation to Speak, European Society of Anaesthethics 2007)
    • PhD Student Award (British Society of Haemostasis & Thrombosis 2006)
    • Invited Speaker (Invitation to Speak, Universität Frankfurt 2005)
    • Invited Speaker (Invitation to Speak, International Society on Thrombosis and Haemostasis Scientific and Standardisation Sub-committee 2005)
    • International Expert in Disseminated Intravascular Coagulation (Invitation to Speak, University of Texas 2005)
    • Patent (Europe 2005)
    • Patent (Europe 2005)
    • Patent (USA 2005)
    • Invited Speaker (Invitation to Speak, Imperial College London 2005)
    • Invited Speaker (Invitation to Speak, University of Sheffield 2005)
    • Invited Speaker (Invitation to Speak, International Society on Thrombosis & Haemostasis Scientific and Standardisation Sub-committee 2004)
    • Invited Speaker (Invitation to Speak, East Anglia Intensive Care Group 2004)
    • Invited Speaker (Invitation to Speak, Northern Region Haematology Group 2004)
    • Invited Speaker (Invitation to Speak, Royal Society of Medicine 2004)
    • Invited Speaker (Invitation to Speak, University of Texas MD Anderson Cancer Centre, USA 2004)
    • Invited Speaker (Invitation to Speak, European Congress of Clinical Microbiology and Infectious Diseases 2003)
    • Invited Speaker (Invitation to Speak, King¿s College Hospital, London 2003)
    • Invited Speaker (Invitation to Speak, British Society of Haematology 2002)
    • Invited Speaker (Invitation to Speak, British Society of Haematology Clinical Science Forum 2002)
    • Invited Speaker (Invitation to Speak, Intensive Care Society, Scotland 2002)
    • Invited Speaker (Invitation to Speak, Edinburgh Royal Infirmary 2002)
    • Invited Speaker (Invitation to Speak, International Society on Thrombosis and Haemostasis Scientific and Standardisation Sub-committee 2002)
    • Invited Speaker (Invitation to Speak, International Society on Thrombosis and Haemostasis Scientific & Standardisation Sub-committee 2002)
    • Invited Speaker (Invitation to Speak, Japanese DIC Committee 2002)
    • Patent (USA 2002)
    • Invited Speaker (Invitation to Speak, Advancing Laboratory Practice in Haematology 2001)
    • Invited Speaker (Invitation to Speak, Sepsis Care Initiative Meeting 2001)
    • Invited Speaker (Invitation to Speak, EPSRC meeting 2001)
    • PhD Student Award (British Society of Haemostasis & Thrombosis 2000)
    • Young Investigator Award (Prize, British Society of Haemostasis & Thrombosis 1992)

    Administrative Roles

    • LOCAL:
    • Clinical Director, Roald Dahl Haemostasis & Thrombosis Centre, Liverpool.
    • Lead, Cheshire & Merseyside Clinical Research Network in Non-Malignant Haematology
    • NATIONAL:
    • MRC Cardiovascular Expert Panel
    • UK Haemophilia Centre Doctors Organisation Advisory Panel
    • INTERNATIONAL:
    • President, International Society on Thrombosis and Haemostasis Scientific and Standardization Committee 2012.
    • Chair, European Hematology Association Curriculum Committee.
    • Co-chair, European Hematology Association Education Committee
    • Editorial Advisory Panel: Journal of Thrombosis & Haemostasis